BIO4 Campus attended Swiss Biotech Day 2026 in Basel, where discussions covered areas directly relevant to what BIO4 is building: AI-driven drug discovery, liquid biopsy applications in oncology, lab automation and virtual simulation, clinical R&D infrastructure, and cross-border partnerships connecting Europe with Asian markets.

The startup pitches showcased early-stage companies working on technologies that will likely define the next decade of biotech. The event provided insight into how advanced ecosystems structure collaboration between research, startups, and industry.

Learning from established biotech hubs

BIO4 also visited SwissRockets offices and met teams working on innovations in biotech infrastructure and services — conversations that offered practical perspective on how mature ecosystems support growth, knowledge transfer, and commercial translation.

Walking through the Global Village, one pattern was clear: biotech ecosystems that integrate AI, data infrastructure, and translational science in one physical location are becoming the model. That's the approach BIO4 Campus is taking in Belgrade.

The participation strengthened connections with European biotech stakeholders and provided a clearer view of where the sector is moving — insights that inform BIO4's continued development and international positioning.